Expert Opinion on Drug Metabolism & Toxicology
Title Abbreviation
Expert Opin Drug Metab Toxicol
Electronic ISSN
1744-7607
Readership
Academics, Clinical Pharmacologists, Clinicians, Industrial Scientists, Managers, Molecular Biologists, Pharmaceutical Benefits Managers, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Scientists, Toxicologists
Scope
Expert Opinion on Drug Metabolism & Toxicology [ISSN 1742-5255]; [e-ISSN 1744-7607] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers on all aspects of ADME-Tox.
Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.
Expert Opinion on Drug Metabolism & Toxicology addresses the needs of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.
The Editors welcome:
Reviews covering: metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data; Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Taylor & Francis, Inc. - UK
To see more details about Expert Opinion on Drug Metabolism & Toxicology,
Subscribe Now!
Impact Factor
JCR Categories/Rank
Circulation
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Acceptance to Print Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines